Table 3 Laboratory investigations of HSP patients stratified by the presence of MEFV mutations
From: MEFV gene mutations in Egyptian children with Henoch-Schonlein purpura
Variable | Mutation (-) | At least one mutation(+) | P-value |
|---|---|---|---|
n = 23 (38.3%) | n = 37 (61.7%) | ||
*Anaemia | 7(30.4%) | 9(24.3%) | 0.6 |
*Leukocytosis | 10(43.5%) | 11(29.7%) | 0.278 |
*Thrombocytopenia | 2(8.7%) | 1(2.7%) | 0.552 |
ESR(mean ± SD) | 36.70 ± 20.007 | 37.04 ± 27.466 | 0.96 |
Positive CRP | 11(47.8%) | 11(29.7%) | 0.157 |
•Elevated ASOT | 7(30.4%) | 5(13.5%) | 0183 |
Heamaturia | 5(21.7%) | 6(16.2%) | 0.734 |
Protienuria | 8(34.8%) | 7(18.9%) | 0..168 |
Elevated urea and creatinine | 0 | 1(2.7%) | 1 |
Positive stool for occult blood | 5(21.7%) | 10(27%) | 0.646 |